Genomics & Precision Medicine

(SLB-052) AI-assisted pharmacogenomics tool can assist in Sickle cell disease management and reduce treatment costs

(SLB-055) Antidepressant Drug Switching in the Swiss population with a focus on Escitalopram and drugs with pharmacogenetic dosing guidelines: A drug utilization study using claims data

(SLB-053) Association of serum vitamin D status with VDR and CAMP gene expression and their influence on biofilm formation in diabetic foot patients

(SLB-057) Exposure to multiple drugs with actionable pharmacogenetic biomarkers among older adults in China: A retrospective analysis

(SLB-054) Genetically perturbed plasma sclerostin level and incident ischemic stroke

(SLB-051) Predictors of Genetic Testing Among Patients With Non-Small Cell Lung Cancer Receiving Targeted Therapy

(SLB-056) Real-World Consequences of Drug-Gene Interactions in a National Healthcare System